N-Fmoc-2-methylbenzyl-glycine is an aromatic glycine derivative where ortho-methyl substitution introduces steric asymmetry. The residue influences side-chain orientation and hydrophobic clustering in designed peptides. Researchers employ it for linker design and conformational tuning. Its Fmoc protection supports multistep synthetic schemes.
CAT No: R2149
CAS No:2137983-02-7
Synonyms/Alias:N-Fmoc-2-methylbenzyl-glycine;2137983-02-7;{[(9H-fluoren-9-ylmethoxy)carbonyl][(2-methylphenyl)methyl]amino}acetic acid;EN300-81242;F80953;2-[9H-fluoren-9-ylmethoxycarbonyl-[(2-methylphenyl)methyl]amino]acetic acid;N-(((9H-FLUOREN-9-YL)METHOXY)CARBONYL)-N-(2-METHYLBENZYL)GLYCINE;2-({[(9H-fluoren-9-yl)methoxy]carbonyl}[(2-methylphenyl)methyl]amino)acetic acid;
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More